Effect of applying the new Clinical and Laboratory Standards Institute ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and imipenem susceptibility breakpoints for Pseudomonas aeruginosa in Hong Kong. - Suppr | 超能文献

Effect of applying the new Clinical and Laboratory Standards Institute ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and imipenem susceptibility breakpoints for Pseudomonas aeruginosa in Hong Kong.

作者信息

Ho Pak-Leung, Chow Kin-Hung, Tse Herman, Cheng Vincent C C

出版信息

Int J Antimicrob Agents. 2012 Sep;40(3):280-1. doi: 10.1016/j.ijantimicag.2012.05.008. Epub 2012 Jul 12.

DOI:10.1016/j.ijantimicag.2012.05.008

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Effect of applying the new Clinical and Laboratory Standards Institute ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and imipenem susceptibility breakpoints for Pseudomonas aeruginosa in Hong Kong.

Int J Antimicrob Agents. 2012 Sep;40(3):280-1. doi: 10.1016/j.ijantimicag.2012.05.008. Epub 2012 Jul 12.

2

Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase.β-内酰胺类药物单独及与β-内酰胺酶抑制剂联合应用对具有诱导型β-内酰胺酶的铜绿假单胞菌的药效学研究。

J Antimicrob Chemother. 2004 Feb;53(2):297-304. doi: 10.1093/jac/dkh057. Epub 2004 Jan 16.

3

Comparison of different methods for determining beta-lactam susceptibility in Pseudomonas aeruginosa.铜绿假单胞菌中β-内酰胺敏感性不同测定方法的比较

New Microbiol. 2012 Oct;35(4):491-4. Epub 2012 Oct 1.

4

Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis.头孢洛扎/他唑巴坦、头孢他啶、美罗培南和哌拉西林/他唑巴坦对从囊性纤维化患儿中分离出的铜绿假单胞菌的微生物活性。

Diagn Microbiol Infect Dis. 2015 Sep;83(1):53-5. doi: 10.1016/j.diagmicrobio.2015.04.012. Epub 2015 May 1.

5

Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals: CANWARD 2008-2011.2008-2011 年加拿大医院分离的铜绿假单胞菌的药敏情况：CANWARD 研究。

Diagn Microbiol Infect Dis. 2012 Aug;73(4):361-4. doi: 10.1016/j.diagmicrobio.2012.05.007. Epub 2012 Jun 12.

6

Accuracy of automated and manual systems for susceptibility testing of Pseudomonas aeruginosa to piperacillin and piperacillin-tazobactam.铜绿假单胞菌对哌拉西林和哌拉西林-他唑巴坦药敏试验的自动化和手动系统的准确性

New Microbiol. 2011 Jan;34(1):97-9. Epub 2011 Jan 15.

7

Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents.三种自动化系统（MicroScan WalkAway、VITEK和VITEK 2）对铜绿假单胞菌针对五种广谱β-内酰胺类药物药敏试验的准确性。

J Clin Microbiol. 2006 Mar;44(3):1101-4. doi: 10.1128/JCM.44.3.1101-1104.2006.

8

Antimicrobial susceptibility of Pseudomonas aeruginosa in China: a review of two multicentre surveillance programmes, and application of revised CLSI susceptibility breakpoints.中国铜绿假单胞菌的药敏情况：两项多中心监测项目的回顾，以及修订后的 CLSI 药敏折点的应用。

Int J Antimicrob Agents. 2012 Nov;40(5):445-9. doi: 10.1016/j.ijantimicag.2012.07.002. Epub 2012 Aug 19.

9

Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.囊性纤维化中心的抗菌药物使用情况及铜绿假单胞菌药敏谱

Int J Antimicrob Agents. 2005 Mar;25(3):193-7. doi: 10.1016/j.ijantimicag.2004.11.009.

10

Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.先前的环丙沙星暴露与后续铜绿假单胞菌菌血症分离株对β-内酰胺类抗生素的耐药性有关。

Am J Infect Control. 2009 Nov;37(9):753-8. doi: 10.1016/j.ajic.2009.02.003. Epub 2009 May 31.

引用本文的文献

1

Synthesis, Characterization and Biological Activities of New Schiff Base Compound and Its Lanthanide Complexes.新型席夫碱化合物及其镧系配合物的合成、表征与生物活性

Pharmaceuticals (Basel). 2022 Apr 7;15(4):454. doi: 10.3390/ph15040454.

2

Ecthyma gangrenosum and ecthyma-like lesions: review article.坏疽性脓皮病及类坏疽性损害：综述文章

Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):633-9. doi: 10.1007/s10096-014-2277-6. Epub 2014 Nov 19.